The BioPharm Brief: Trials Expand Cancer, Eye Disease and Obesity Care

Welcome to The BioPharm Brief, your daily snapshot of the latest developments shaping biopharmaceutical research, clinical progress, and regulatory strategy. Today’s update covers a new immunotherapy option for colon cancer, progress in treating chronic thyroid eye disease, and emerging data for an investigational obesity treatment.